[1]
|
You, D., New, J.R. and Wardlaw, T. (2012) The report 2012 of levels & trends in child mortality. Unicef, WHO, The World Bank. Uhttp://www.unicef.org/videoaudio/PDFs/UNICEF_2012_child_mortality_for_web_0904.pdfU
|
[2]
|
Zarb, P. and Goossens, H. (2012) Human use of antimicrobial agents. Revue Scientifique et Technique, 31, 121-133.
|
[3]
|
Zaidi, A.K., Tikmani, S.S., Warraich, H.J., Darmstadt, G.L., Bhutta, Z.A., Sultana, S. and Thaver, D. (2012) Community-based treatment of serious bacterial infections in newborns and young infants: A randomized controlled trial assessing three antibiotic regimens. Pediatric Infectious Disease Journal, 31, 667-672. Uhttp://dx.doi.org/10.1097/INF.0b013e318256f86cU
|
[4]
|
Lodha, R., Kabra, S.K. and Pandey, R.M. (2013) Antibiotics for community-acquired pneumonia in children. Cochrane Database of Systematic Reviews, 6, Article ID: CD004874. Uhttp://dx.doi.org/10.1002/14651858.CD004874.pub4U
|
[5]
|
Holloway, K. and Van Dijk, L. (2011) The World Medicines Situation 2011, rational use of medicines. 3rd Edition, World Health Organization, Geneva.
|
[6]
|
WHO (2009) Medicines use in primary care in developing and transitional countries: Fact book summarizing results from studies reported between 1990 and 2006. World Health Organization, Geneva. Uhttp://www.who.int/medicines/publications/primary_care_8April09.pdfU
|
[7]
|
WHO (2006) Using indicators to measure country pharmaceutical situations: Fact book on WHO Level I and Level II monitoring indicators. World Health Organization, Geneva. Uhttp://apps.who.int/medicinedocs/index/assoc/s14101e/s14101e.pdfU
|
[8]
|
Risk, R., Naismith, H., Burnett, A., Moore, S.E., Cham, M. and Unger, S. (2013) Rational prescribing in paediatrics in a resource-limited setting. Archives of Disease in Childhood, 98, 503-509. Uhttp://dx.doi.org/10.1136/archdischild-2012-302987U
|
[9]
|
Abba, K., Sinfield, R., Hart, C.A. and Garner, P. (2009) Antimicrobial drugs for persistent diarrhoea of unknown or non-specific cause in children under six in low and middle income countries: Systematic review of randomized controlled trials. BMC Infectious Diseases, 9, 24.
|
[10]
|
Ganguly, N.K., Arora, N.K., Chandy, S.J., Fairoze, M.N., Gill, J.P., Gupta, U., Hossain, S., Joglekar, S., Joshi, P.C., Kakkar, M., Kotwani, A., Rattan, A., Sudarshan, H., Thomas, K., Wattal, C., Easton, A., Laxminarayan, R. and Global Antibiotic Resistance Partner-ship (GARP)—India Working Group (2011) Rationalizing antibiotic use to limit antibiotic resistance in India. The Indian Journal of Medical Research, 134, 281-294.
|
[11]
|
Blomberg, B. (2008) Antimicrobial resistance in developing countries. Tidsskr Nor Laegeforen, 128, 2462-2466.
|
[12]
|
Goossens, H. (2009) Antibiotic consumption and link to resistance. Clinical Microbiology and Infection, 15, S12-S15. Uhttp://dx.doi.org/10.1111/j.1469-0691.2009.02725.xU
|